Schrödinger, Inc.

NASDAQ:SDGR

Medical - Healthcare Information Services

Healthcare
$27.20 +0.01%

+$0.00 today

Market cap
$1.79B
Beta
1.64
P/E (TTM)
-11.1
EPS (TTM)
-$1.40
52W Low $10.95High $23.75

Volume 1.18M

Average 1.35M

SDGR Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Schrödinger, Inc.NASDAQ: SDGR

Other Income / Expenses · Q3 FY2026 · quarter ended Sep 2026

Other income / expenses turns negative

Q3 FY2026 other income / expenses was -$11.43M, compared with $13.31M a year earlier. Trailing-twelve-month other income / expenses was $76.77M.

Context

  • Other income / expenses amounted to 25.2% of revenue in FY2025, up 13.9 pp from a year earlier.
  • Other income / expenses increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly other income / expenses holds near -$11.43M or moves back toward the trailing-twelve-month quarterly average of $19.19M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$11.43M-123.4% QoQ
Last fiscal yearDec 2025
$64.57M+173.8% YoY
LTMSep 2026
$76.77M+1972.1% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-185.8%——
1 year+173.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
64.57M USD
Year-over-year change
+173.8%
4-year CAGR
+57.0%

Other Income / Expenses vs competitors

How SDGR compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +1972.1% is the highest of 9, against a peer median of -33.4%.
  • Other income / expenses amounts to 28.5% of revenue for SDGR, versus a peer median of 8.5%.
SDGR Competitors
Other Income / Expenses for SDGR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VEEVVeeva Systems Inc.LTM Jul 2026$292.52M USD+16.0%+77.2%8.5%
SDGRSchrödinger, Inc.LTM Sep 2026$76.77M USD+1972.1%—28.5%
ABCLAbCellera Biologics Inc.LTM Sep 2026$31.38M USD-44.3%+20.5%46.2%
RLAYRelay Therapeutics, Inc.LTM Jun 2026$24.4M USD-22.6%+44.2%235.7%
GENBGenerate Biomedicines, Inc.FY2025$12.26M USD-22.2%—38.5%
SLPSimulations Plus, Inc.LTM Feb 2026$925K USD-81.4%+87.8%1.1%
LTRNLantern Pharma Inc.LTM Mar 2026$697.88K USD-49.5%+70.7%—
HYFTMindWalk Holdings Corp.LTM Jan 2026-CA$1.17M CAD+96.8%—6.4%
CERTCertara, Inc.LTM Mar 2026-$22.21M USD-54.4%—5.3%
Peer median (excluding SDGR) —-33.4%+70.7%8.5%

Competitors are the stored peer set for SDGR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue137.93M180.96M216.67M207.54M255.87M
Cost of Revenue72.31M79.93M75.97M75.46M113.26M
Gross Profit65.62M101.02M140.69M132.08M142.61M
Gross Margin47.6%55.8%64.9%63.6%55.7%
Research & Development90.9M126.37M181.77M201.79M173.14M
Selling, General & Admin86.16M121.47M136.37M139.59M136.37M
Operating Expenses177.06M247.84M318.14M341.38M309.51M
Depreciation & Amortization2.85M4.34M5.55M6.16M6.02M
EBITDA(97.96M)(144.78M)48.47M(179.55M)(96.3M)
EBITDA Margin-71.0%-80.0%22.4%-86.5%-37.6%
Operating Income(111.44M)(146.82M)(177.45M)(209.3M)(166.9M)
Operating Margin-80.8%-81.1%-81.9%-100.8%-65.2%
Interest Income1.06M3.95M000
Interest Expense03K000
Other Income / Expenses10.64M(2.31M)220.37M23.59M64.57M
Income Before Tax(100.81M)(149.12M)42.92M(185.71M)(102.33M)
Pre-Tax Margin-73.1%-82.4%19.8%-89.5%-40.0%
Income Tax Expense411K63K2.2M1.41M939K
Net Income(100.39M)(149.19M)40.72M(187.12M)(103.27M)
Net Margin-72.8%-82.4%18.8%-90.2%-40.4%
EPS (Basic)(1.43)(2.10)0.57(2.57)(1.41)
EPS (Diluted)(1.43)(2.10)0.54(2.57)(1.41)
Weighted Avg Shares70.59M71.17M71.78M72.67M73.44M
Weighted Avg Shares (Diluted)70.59M71.17M74.99M72.67M73.44M

Schrödinger, Inc.

NASDAQ:SDGR

Intrinsic Alpha fair value

Locked

Current Price

$27.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.